Day July 2, 2024
Gastroesophageal reflux disease increases risk for atrial fibrillation: Study
U.S. government to pay Moderna $176 million to develop mRNA flu vaccine
Transgender and gender-diverse people’s health care experiences
Drugs that kill ‘zombie’ cells may benefit some older women, but not all
Genetic test improves clinical care for children with cancer in England
Implantable microphone could lead to fully internal cochlear implants
Behavioral health researchers study hundreds of brain scans to explore the biology of depression
Sorting therapeutic stem cells by function improves healing after heart attack, lab study shows
New brain surgery approach targets difficult tumors at skull base
Dengue fever confirmed in Florida Keys as US on watch for rise in mosquito illness
Racial differences seen in financial hardship among older cancer survivors
Research team identifies target protein regulating autoimmune disease lupus
Housing insecurity linked to poorer teen health outcomes
Destroying cancer-causing RNA could lead to bespoke treatments
The efficiency of PspCas13b silencing is highly variable between crRNAs. Credit: Nature Structural & Molecular Biology (2024). DOI: 10.1038/s41594-024-01336-0 Peter Mac researchers have taken the first step towards designing rapid personalized cancer treatments by ‘cutting out’ disease-causing RNA. The findings,…
The importance of HIV testing
Chorus or cacophony? Cicada song hits some ears harder than others
New lab test to detect persistent HIV strains in Africa may aid search for cure
Too much treadmill? This could help your shin splints
Wide-ranging study identifies suicide risk factors to improve prevention
Predictor selection, SHAP visualization and performance of machine-learning classification model based on behavior-related phenotypes. a, Sequential forward selection of behavior-related variables. b, SHAP visualization of selected predictors. c, AUC plots for the behavior-related phenotype-based SA classification model. Credit: Nature Human…
Predicting new pandemics through data analysis of recombinant virus genomes
Researchers examine cancer drug guidelines and FDA approvals
Timing (by year) of FDA accelerated approval status of oncology therapeutic indications, results of postapproval confirmatory trial availability as publications, conversion to traditional approval or market withdrawal, and NCCN guideline updates. There were no duplicate indications; several drug treatments were…
